
DOJ Increases FCA Penalties
The U.S. Department of Justice recently announced inflationary increases to civil monetary penalties under the False Claims Act.
The U.S. Department of Justice recently announced inflationary increases to civil monetary penalties under the False Claims Act.
This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.